share_log

Genetic Technologies Limited (ASX:GTG) Insider Sells A$38,400.00 in Stock

Financial News Live ·  Feb 6, 2023 10:32

Genetic Technologies Limited (ASX:GTG – Get Rating) insider Jerzy (George) Muchnicki sold 38,400,000 shares of the stock in a transaction that occurred on Monday, January 30th. The stock was sold at an average price of A$0.00 ($0.00), for a total transaction of A$38,400.00 ($27,042.25).

Genetic Technologies Stock Performance

The company has a debt-to-equity ratio of 3.97, a quick ratio of 3.72 and a current ratio of 3.86.

Get Genetic Technologies alerts:

About Genetic Technologies

(Get Rating)

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate.

See Also

  • 2023 Consumer Lending Study – Trends, Statistics, and Forecast
  • Here's the Silver Lining with Snap Stock Earnings Collapse
  • Mullen Automotive Stock, The Tide Has Turned
  • Is BigBear.ai Stock a Diamond in the Rough?
  • Apple: What's The Post-Earnings Play?

Receive News & Ratings for Genetic Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genetic Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment